Fig. 4

(A) Untreated MDA-MB-231 control cells, (B) Cells exposed to Galangin, (C) Cells treated with SAHA, and (D) Cells subjected to the combined treatment of Galangin and SAHA, (E) Percent distribution of cell populations across different cell cycle phases, (F) Control cells with a predominant live cell population. Apoptotic-mediated cell death induced by (G) Galangin, (H) SAHA, and (I) Galangin and SAHA combination, (J) Quantified apoptotic-mediated cell death in MDA-MB-231 cells, categorized as Q1: Necrotic, Q2: Apoptotic, Q3: Live, and Q4: Early apoptotic cells